Bay Area
September 24, 2024: How AI is Changing the Pharma & Biotech Industry
Cheryl Cheng, Founder & CEO, Vive Collective
Jim Martineau, Co-founder, Nosis Bio
Lana Feng, Co-founder & CEO, Huma.AI
Raphael Townshend, Founder & CEO, Atomic AI
Tomasz Jetka, Director of AI & Data Science, Ardigen
Moderated by Ekaterine Kortkhonjia, Sr. Director, Early Innovation Partnering, Johnson & Johnson
March 27, 2024: The Expanding Role of Pharma in our Ecosystem
Jacob Borrajo, CEO, Amber Bio
Jessica Grossman, CEO, IgGenix
Jorge Conde, General Partner, Andreesen Horowitz
Judith Li, Partner, Lilly Asia Ventures
Moderated by Tim Luker, Lilly West Coast Venture Science Head, Lilly
September 28, 2023: Implications of the IRA
Dina Lynch, VP Market Access & Managed Care, Alzheon
Jason Punwani, Partner, Abingworth
Katie McCarthy, Chief Innovation Officer, Halloran Consulting Group
Leigh Ann Bruhn, EVP Value & Access, Syneos Health
Moderated by Mark Spring, Managing Partner, Danforth Advisors
April 25, 2023: Development & Manufacturing Challenges of Cell & Gene Therapies
Barbra Sasu, CSO, Allogene
David Schaffer, Director, Bakar BioEnginuity Hub & Bakar Labs
Faraz Siddiqui, SVP, Manufacturing Operations, IGM Biosciences
Julien Meissonnier, CSO, Catalent Pharma Solutions
Nicole Paulk, Assistant Professor, UCSF
Moderated by Chris Mason, Co-founder & former CSO, AVROBIO
September 8, 2022: Current & Future State of M&A
Darcy Mootz, Head, Amunix Pharmaceuticals
Jay Stamatis, VP & Head of BD & Acquisitions, AbbVie
Julianne Averill, CFO consultant, Danforth Advisors
Lori Hu, Managing Director, Vertex Ventures HC
Moderated by Samina Bari, Strategic Business Advisor, Cayuga Biotech
May 24, 2022: Status of the Industry
Anne Longmire, VP, JP Morgan
Brent Vaughan, CEO, Cognito Therapeutics
Mike Guerra, CEO, CA Life Sciences
Shelley Chu, Partner, Lightspeed Venture Partners
Moderated by Ben Conway, consultant, Danforth Advisors